Clinical Trial Update: Reducing Proviral HIV DNA With Interferon-a [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from The Wistar Institute is evaluating interferon-alpha to reduce proviral HIV DNA in people with HIV infection/AIDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Interferon-alpha (interferon alpha)

Snippet

Sponsor: The Wistar Institute | Conditions: HIV, HIV/AIDS | Phase 2 | Status: UNKNOWN